Abstract
Concomitant with increases in prescriptions for controlled opioids, rates of nonmedical use of prescription opioids (NMUPO) have increased, including among adolescents aged 12-19 years. Adolescent NMUPO poses particular problems for clinicians, as prescribing physicians and dentists serve as the primary source of opioids for NMUPO in the majority of cases. Furthermore, early initiation of NMUPO appears to increase the risk of developing opioid dependence in adulthood. Given the significant morbidity and mortality associated with adolescent NMUPO, steps taken by clinicians to limit the scope of this phenomenon are needed. This article aims to aid clinicians by reviewing the literature on adolescent NMUPO and making specific recommendations to limit the scope of adolescent NMUPO.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
